Table 1.
The number of CD11b+, CD14+, or complement factor I (CFI)+ cells and the staining score of iC3b in skin biopsies from patients with immunocomplex-mediated cutaneous small vessel vasculitis.
| CD11b (cells/mm2) | CD14 (cells/mm2) | CFI (cells/mm2) | iC3b (score) | |
|---|---|---|---|---|
| Nonlesional skin (n = 10) | 264 ± 162 | 224 ± 117 | 124 ± 144 | 1.3 ± 0.5 |
| Initial petechiae (n = 10) | 853 ± 605∗ | 576 ± 330# | 270 ± 168& | 1.6 ± 0.7 |
| Palpable purpura (n = 8) | 2040 ± 1202∗∗ | 1115 ± 606## | 219 ± 69 (n = 9) | 2.6 ± 0.7∗∗∗ |
The results are expressed as the mean ± standard deviation. “∗” denotes p = 0.014 and “∗∗” p = 0.004 when the CD11b+ cell numbers in the initial petechial lesion and palpable purpura, respectively, were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); “#” denotes p = 0.008 and “##” p = 0.0024 when the CD14+ cell numbers in the initial petechial lesion and palpable purpura, respectively, were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); “&” denotes p = 0.0169 when the CFI+ cell numbers in the initial petechial lesion were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); and “∗∗∗” denotes p = 0.003 when the iC3b scores in the palpable purpura were compared to the corresponding scores in the nonlesional skin (mixed model analysis).